POST SUMMARY: 70 percent of all Americans are on at least one prescription drug, and 20 percent of all Americans are on at least five prescription drugs and according to the CDC, approximately 9 out of every 10 Americans that are at least 60 years old say that they have taken at least one prescription drug within the last month. Are we treating patients with an Rx when they might need other forms of treatments?
POST SUMMARY: Consumers don’t trust big pharma, but hey are going online in bigger numbers to get health information. If we want to be part of the conversation we need to EARN their trust one patient at a time. It’s not going to be easy, but we need to fight for patients at every meeting and within every online digital interaction.
POST SUMMARY: To say that 2014 has been a challenging year for pharma would be an understatement. Budget cuts are kicking in and 86% of Rx’s are now generic medications while sales and marketing budgets have hit a dead end. More than that a lot of very talented and good DTC marketing people have left the industry because job satisfaction is a lot more important than a paycheck.
POST SUMMARY: A guest post, last week, on the digital pharma conference led to a lot of comments with very strong opinions on both sides. The author sent me the post on condition that he would remain anonymous because his company does not allow employees to write articles without first going through a maze of approvals. However, he does raise some very good points.
GUEST POST - I’m a Senior Director for a top pharmaceutical company here on the East Coast and manage 6 digital marketing people, but I am not going to attend the Digital Pharma East. I would like to share the reasons and give you some pause as to whether you should go or use the time, and money, more wisely.
POST SUMMARY: There is nothing like a bunch of ad executives getting together at a French resort to pat each other on the back for advertising, even id the ads were ineffective in driving brand objectives. According to the “jury” the pharma category, although there was good work, and much of it included digital components, the jurors found that there was “a lot of utility but not so much beauty.” P L E A S E !!!
POST SUMMARY: IBS affects between 25 and 45 million people in the United States (10 to 15% of the population). About 2 in 3 IBS sufferers are female. About 1 in 3 IBS sufferers are male. IBS affects people of all ages, even children. Although IBS is common in the general population, few seek medical care for their symptoms, so I have to wonder why Ironwood and Forest are taking such a bad approach to the DTC marketing for Linzess.
POST SUMMARY: Consumers today don’t want to be “sold”, they want credible, transparent health information to help them make healthcare decisions. However, the online environment of health information is often confusing and hard to understand, which in turn means that consumers have to spend more time online trying to get their health questions answered. There is a major opportunity for biopharma DTC marketers to make the leap from a website that “sells” to a website that provides answers.